Login / Signup

Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants.

Waleed S Al AmriDiana E BaxterAndrew M HanbyLucy F SteadEldo T VergheseJames L ThorneThomas A Hughes
Published in: Breast cancer research and treatment (2020)
Genomic analysis of paired pre- and post-therapy samples resulting from neoadjuvant therapy provides a powerful method for identification of mediators of response. Genes we identified should be assessed as predictive markers or targets in chemo-sensitization.
Keyphrases